Peyronie's Disease Treatment Costs Have Risen
The number of men being treated for Peyronie's disease has increased over the past decade or so, experts have reported. And with that, so have treatment costs.
According to a recent study in Sexual Medicine, the average per-patient cost grew 5-fold between 2007 and 2018.
Using health insurance information from 88,642 men, the researchers compared costs for oral medications, injection therapy, and surgery.
Injection therapy increased the most. In 2007, the average cost for a course of injections was $811 per patient. By 2018, that figure had jumped to $16,184.
Why did injections become so much more expensive? Read more.
Oral Testosterone an Option for Certain Men with Low T
Last year, the U.S. Food and Drug Administration (FDA) approved Jatenzo, an oral form of testosterone therapy, for certain men with testosterone deficiency.
Recently, additional details on the safety and efficacy of the drug were published.
In a 4-month trial, researchers analyzed the outcomes of 166 men taking Jatenzo and 56 men using a testosterone gel.
Both medication forms brought the men's testosterone levels to a normal range.
However, researchers were concerned about side effects of Jatenzo, especially blood pressure increases. See more details.
|
